Actinium Pharmaceuticals, Inc. (ATNM)
NYSE: ATNM · CIK 0001388320 · United States
Every official Actinium Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ATNM filings
Actinium Pharmaceuticals, Inc. documents
- Actinium Pharmaceuticals, Inc. 10-K 2026ATNM 10-K 2026: annual report for fiscal 2026
- Actinium Pharmaceuticals, Inc. 10-K 2025ATNM 10-K 2025: annual report for fiscal 2025
- Actinium Pharmaceuticals, Inc. 10-K 2024ATNM 10-K 2024: annual report for fiscal 2024
- Actinium Pharmaceuticals, Inc. 10-K 2023ATNM 10-K 2023: annual report for fiscal 2023
- Actinium Pharmaceuticals, Inc. 10-K 2022ATNM 10-K 2022: annual report for fiscal 2022
- Actinium Pharmaceuticals, Inc. 10-Q 2026ATNM 10-Q 2026: quarterly report for fiscal 2026
- Actinium Pharmaceuticals, Inc. 10-Q 2025ATNM 10-Q 2025: quarterly report for fiscal 2025
- Actinium Pharmaceuticals, Inc. 10-Q 2024ATNM 10-Q 2024: quarterly report for fiscal 2024
- Actinium Pharmaceuticals, Inc. 10-Q 2023ATNM 10-Q 2023: quarterly report for fiscal 2023
- Actinium Pharmaceuticals, Inc. 10-Q 2022ATNM 10-Q 2022: quarterly report for fiscal 2022
- Actinium Pharmaceuticals, Inc. 8-K 2026ATNM 8-K 2026: current report for fiscal 2026
- Actinium Pharmaceuticals, Inc. 8-K 2025ATNM 8-K 2025: current report for fiscal 2025
- Actinium Pharmaceuticals, Inc. 8-K 2024ATNM 8-K 2024: current report for fiscal 2024
- Actinium Pharmaceuticals, Inc. 8-K 2023ATNM 8-K 2023: current report for fiscal 2023
- Actinium Pharmaceuticals, Inc. 8-K 2022ATNM 8-K 2022: current report for fiscal 2022
- Actinium Pharmaceuticals, Inc. DEF 14A 2026ATNM DEF 14A 2026: proxy statement for fiscal 2026
- Actinium Pharmaceuticals, Inc. DEF 14A 2025ATNM DEF 14A 2025: proxy statement for fiscal 2025
- Actinium Pharmaceuticals, Inc. DEF 14A 2024ATNM DEF 14A 2024: proxy statement for fiscal 2024
- Actinium Pharmaceuticals, Inc. DEF 14A 2023ATNM DEF 14A 2023: proxy statement for fiscal 2023
- Actinium Pharmaceuticals, Inc. DEF 14A 2022ATNM DEF 14A 2022: proxy statement for fiscal 2022
- Actinium Pharmaceuticals, Inc. Form 4 2026ATNM Form 4 2026: insider trading filing for fiscal 2026
- Actinium Pharmaceuticals, Inc. Form 4 2025ATNM Form 4 2025: insider trading filing for fiscal 2025
- Actinium Pharmaceuticals, Inc. Form 4 2024ATNM Form 4 2024: insider trading filing for fiscal 2024
- Actinium Pharmaceuticals, Inc. Form 4 2023ATNM Form 4 2023: insider trading filing for fiscal 2023
- Actinium Pharmaceuticals, Inc. Form 4 2022ATNM Form 4 2022: insider trading filing for fiscal 2022
- Actinium Pharmaceuticals, Inc. S-1 2026ATNM S-1 2026: registration statement for fiscal 2026
- Actinium Pharmaceuticals, Inc. S-1 2025ATNM S-1 2025: registration statement for fiscal 2025
- Actinium Pharmaceuticals, Inc. S-1 2024ATNM S-1 2024: registration statement for fiscal 2024
- Actinium Pharmaceuticals, Inc. S-1 2023ATNM S-1 2023: registration statement for fiscal 2023
- Actinium Pharmaceuticals, Inc. S-1 2022ATNM S-1 2022: registration statement for fiscal 2022
- Actinium Pharmaceuticals, Inc. 13F 2026ATNM 13F 2026: institutional holdings for fiscal 2026
- Actinium Pharmaceuticals, Inc. 13F 2025ATNM 13F 2025: institutional holdings for fiscal 2025
- Actinium Pharmaceuticals, Inc. 13F 2024ATNM 13F 2024: institutional holdings for fiscal 2024
- Actinium Pharmaceuticals, Inc. 13F 2023ATNM 13F 2023: institutional holdings for fiscal 2023
- Actinium Pharmaceuticals, Inc. 13F 2022ATNM 13F 2022: institutional holdings for fiscal 2022
More companies